Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ficorella

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|August 5, 2004
Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding studyC Ficorella, M F Morelli, E Ricevuto, et al.
Oncology Reports|April 6, 2006
Increased tolerability of bimonthly 12-hour timed flat infusion 5-fluorouracil/irinotecan regimen in advanced colorectal cancer: A dose-finding studyC Ficorella, E Ricevuto, M F Morelli, et al.
Human Mutation|July 20, 2001
Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancerF Baudi, B Quaresima, C Grandinetti, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
[Familiarity and heredity of tumors in function of an early surgical therapeutic approach]E Ricevuto, Z C Di Rocco, G Cianci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2009
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysisG Di Lorenzo, R Autorino, G Bruni, et al.
Tumori|August 9, 2003
[Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma?]E Ricevuto, P Marchetti, K Cannita, et al.
Oncology Reports|April 30, 2010
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II studyM F Morelli, A Santomaggio, E Ricevuto, et al.
British Journal of Cancer|October 14, 2005
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III studyS De Placido, M Lopez, C Carlomagno, et al.
La Clinica Terapeutica|August 12, 2006
[Clinical guidelines for the management of gastrointestinal stromal tumors]M Lopez, A Comandone, V Adamo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 9, 2019
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudesA Cortellini, A Leonetti, A Catino, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|August 5, 2004
Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding studyC Ficorella, M F Morelli, E Ricevuto, et al.
Oncology Reports|April 6, 2006
Increased tolerability of bimonthly 12-hour timed flat infusion 5-fluorouracil/irinotecan regimen in advanced colorectal cancer: A dose-finding studyC Ficorella, E Ricevuto, M F Morelli, et al.
Human Mutation|July 20, 2001
Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancerF Baudi, B Quaresima, C Grandinetti, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|November 6, 2002
[Familiarity and heredity of tumors in function of an early surgical therapeutic approach]E Ricevuto, Z C Di Rocco, G Cianci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2009
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysisG Di Lorenzo, R Autorino, G Bruni, et al.
Tumori|August 9, 2003
[Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma?]E Ricevuto, P Marchetti, K Cannita, et al.
Oncology Reports|April 30, 2010
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II studyM F Morelli, A Santomaggio, E Ricevuto, et al.
British Journal of Cancer|October 14, 2005
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III studyS De Placido, M Lopez, C Carlomagno, et al.
La Clinica Terapeutica|August 12, 2006
[Clinical guidelines for the management of gastrointestinal stromal tumors]M Lopez, A Comandone, V Adamo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 9, 2019
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudesA Cortellini, A Leonetti, A Catino, et al.
Pageof 6